GR1003205B - Φαρμακοθεραπευτικες χρησεις δυο τετραυδροφουρανικων παραγωγων: τετραυδρο-ν,ν-διμεθυλ-5,5-διφαινυλ-3-φουρανομεθαναμινη (αε14) και τετραυδρο-ν,ν-διμεθυλ-2,2-διφαινυλ-3-φουρανομεθαναμινη (αε37) - Google Patents

Φαρμακοθεραπευτικες χρησεις δυο τετραυδροφουρανικων παραγωγων: τετραυδρο-ν,ν-διμεθυλ-5,5-διφαινυλ-3-φουρανομεθαναμινη (αε14) και τετραυδρο-ν,ν-διμεθυλ-2,2-διφαινυλ-3-φουρανομεθαναμινη (αε37)

Info

Publication number
GR1003205B
GR1003205B GR980100418A GR980100418A GR1003205B GR 1003205 B GR1003205 B GR 1003205B GR 980100418 A GR980100418 A GR 980100418A GR 980100418 A GR980100418 A GR 980100418A GR 1003205 B GR1003205 B GR 1003205B
Authority
GR
Greece
Prior art keywords
furanomethanamine
diphenyl
dimethyl
tetrahydro
tetrahydrofuranics
Prior art date
Application number
GR980100418A
Other languages
English (en)
Inventor
Original Assignee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by filed Critical
Publication of GR1003205B publication Critical patent/GR1003205B/el

Links

Landscapes

  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αυτή αναφέρεται στον συνδυασμό της ανασχετικής δράσης των μορίων αυτών επί των ιονικών διαύλων του νατρίου - η οποία τους επιτρέπει να ελέγχουν την γλουταματεργική δραστηριότητα στον εγκέφαλο - με τον επιλεκτικό μουσκαρινικό αγωνισμό Μ1 ή τον ανταγωνισμό Μ2. Ο συνδυασμός αυτός τους παρέχει αντιαμνησιακές ιδιότητες, χωρίς τις συνήθεις αμνησιακές παρενέργειες των νευροπροστατευτικών και αντιεπιληπτικών.ΰ
GR980100418A 1998-11-16 1998-11-16 Φαρμακοθεραπευτικες χρησεις δυο τετραυδροφουρανικων παραγωγων: τετραυδρο-ν,ν-διμεθυλ-5,5-διφαινυλ-3-φουρανομεθαναμινη (αε14) και τετραυδρο-ν,ν-διμεθυλ-2,2-διφαινυλ-3-φουρανομεθαναμινη (αε37) GR1003205B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR98100418 1998-11-16

Publications (1)

Publication Number Publication Date
GR1003205B true GR1003205B (el) 1999-09-03

Family

ID=10943527

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980100418A GR1003205B (el) 1998-11-16 1998-11-16 Φαρμακοθεραπευτικες χρησεις δυο τετραυδροφουρανικων παραγωγων: τετραυδρο-ν,ν-διμεθυλ-5,5-διφαινυλ-3-φουρανομεθαναμινη (αε14) και τετραυδρο-ν,ν-διμεθυλ-2,2-διφαινυλ-3-φουρανομεθαναμινη (αε37)

Country Status (1)

Country Link
GR (1) GR1003205B (el)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR990100386A (el) * 1999-11-05 2001-07-31 Α ή β (μονο- ή δι-αλκυλαμινομεθυλ)-γ-βουτυρολακτονες και τα αντιστοιχα τους τετραυδροφουρανικα αναλογα σαν νεα πρωτοτυπα νοοτροπα, αντι-ανοικα (ασθενεια του alzheimer), αντιεπιληπτικα και νευροπροστατευτικα φαρμακα με μοναδικο, κατα το μεχρι τουδε .....

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997030983A1 (en) * 1996-02-21 1997-08-28 Alexandre Vamvakides Tetrahydro-n,n-dimethyl-2,2-diphenyl-3-feranemethanamine, its enantiomers, and their pharmaceutically acceptable acid addition salts

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997030983A1 (en) * 1996-02-21 1997-08-28 Alexandre Vamvakides Tetrahydro-n,n-dimethyl-2,2-diphenyl-3-feranemethanamine, its enantiomers, and their pharmaceutically acceptable acid addition salts

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KOLOKOURIS, NICOLAS ET AL: "New amino ethers and amino lactones. Synthesis and pharmacological approach", ANN. PHARM. FR. (1985), 43(3), 257-64 CODEN: APFRAD;ISSN: 0003-4509, XP000607706 *
VAMVAKIDES, A.: "D-cycloserine is active on adult mice and inactive on aged mice, in the forced swim test", ANN. PHARM. FR. (1998), 56(5), 209-212 CODEN: APFRAD;ISSN: 0003-4509, XP002105695 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR990100386A (el) * 1999-11-05 2001-07-31 Α ή β (μονο- ή δι-αλκυλαμινομεθυλ)-γ-βουτυρολακτονες και τα αντιστοιχα τους τετραυδροφουρανικα αναλογα σαν νεα πρωτοτυπα νοοτροπα, αντι-ανοικα (ασθενεια του alzheimer), αντιεπιληπτικα και νευροπροστατευτικα φαρμακα με μοναδικο, κατα το μεχρι τουδε .....

Similar Documents

Publication Publication Date Title
BG101132A (en) Pyridoanilated thienyl and furanyl oxazolidinons
HUP0300207A3 (en) 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
IL150539A0 (en) Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them
EP0960107A4 (el)
YU15299A (sh) Farmaceutski sastavi
MY116896A (en) Taste of active pharmaceutical ingredients.
DE69905170D1 (en) Thiazolopyrimidinderivate
ZA991489B (en) Oxaliplatin solution formulations and the method of use thereof.
IT1313618B1 (it) Derivati di acidi 2-ammino-biciclo(3.1.0)-esan-2,6-bicarbossilici eprocedimento per la loro preparazione.
ZA200300712B (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.
YU2903A (sh) Smeše heparinskih derivata polisaharida, njihovo dobijanje i farmaceutske smeše koje ih sadrže
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
HUP0401567A3 (en) Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
PL346463A1 (en) Method of obtaining derivatives of resorcinol, method of obtaining novel derivatives of 2-oxazabicyclo[2.2.2.]-octan-5-one, method of obtaining novel derivatives of 1,3-cyclohezandione, method of obtaining novel derivatives of 2-cyclohexanone, novel derivatives of 2-oxazabicyclo[2.2.2.]-octan-5-one, novel derivatives of 1,3-cyclohexanodione, and novel derivatives of 2-cyclohexenonea
HUP0105075A3 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them
HUP0302193A3 (en) 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation thereof and pharmaceutical compositions containing them
HUP0102009A3 (en) Synthetic polysaccharides, their method of production and pharmaceutical compositions containing the same
HU9700955D0 (en) Substituted 2-naphtoylguanidine derivatives, their production, their use and pharmaceutical compositions containing them
IL121969A0 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives their preparation and pharmaceutical compositions containing them
BG105275A (en) Tan-1057 derivatives
UA48245C2 (uk) ЗАМІЩЕНІ 1,2,3,4-ТЕТРАГІДРО-2-ДИБЕНЗОФУРАНАМІНИ ТА 2-АМІНОЦИКЛОГЕПТА[B]БЕНЗОФУРАНИ, ФАРМАЦЕВТИЧНА ЛІКАРСЬКА ФОРМА ТА СПОСІБ ПІДВИЩЕННЯ АКТИВАЦІЇ 5-НТ<sub>1F</sub> РЕЦЕПТОРА У ССАВЦЯ
IL139531A0 (en) Human antithrombin iii, methods for the production thereof and pharmaceutical compositions containing the same
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees